Article
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Oct 2013
He Ping, Wang Yan, Yang Sheng, Yu Shufei, Wang Ziping, Li Junling, Wang Bin, Hao Xuezhi, Wang Hongyu, Hu Xingsheng, Zhang Xiangru, Shi Yuankai
Abstract excerpt
BACKGROUND AND OBJECTIVE: Subsequent chemotherapy were needed in patients with advanced pulmonary adenocarcinoma experiencing disease progression after epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment. The study is to explore factors potentially influencing efficacy of subsequent chemotherapy. METHODS: One hundred and ninety-one patients with advanced lung adenocarcinoma, who were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
